Ectopic CIITA/MHC-II expression reprograms tumor microenvironments by displacing immunosuppressive macrophages and neutrophils with activated CD4+/CD8+ T cells, bolstering antitumor immunity 23. The gene discussed is CD8A; the disease is neoplasm.